SFMA is the San Francisco / Bay Area marketing agency for Berkeley companies that need website, SEO, AI visibility, paid ads, positioning, messaging, and conversion paths to produce qualified local demand.
Tuesday morning, 9:47 AM. The Series B is two quarters out. The science is strong. The investor narrative still reads like a research abstract. The board wants commercial-traction proof, not paper proof.
Berkeley operators ship from research. The science is the foundation. Commercial translation is a different function and most teams underbuild it.
By 10:22 the founder asks the question. How do we make the commercial motion legible to a Series B investor without losing the scientific credibility we have spent five years building.
Commercial credibility and scientific credibility are different muscles. Both need to be in writing.
Biotech, edtech, and climate-tech operators in Berkeley face this most acutely. The product is in development; the buyer recognition needs to compound before the product ships.
The Positioning Sprint translates research-led capability into commercial narrative. 14 business days. $7,500 flat. Output covers category narrative, ICP architecture, sales motion definition, and 90-day execution plan.
For Berkeley research-led operators, the Marketing Strategy Review at $5,000 also covers the four-axis architecture in 10 days. The Marketing Review fits when commercial strategy is the primary gap.
Both engagements respect the science. The marketing review does not water down the technical narrative; it produces the parallel commercial narrative the team needs for board, fundraise, and partnership conversations.
Yes. Research-led operators (biotech, edtech, climate tech) face common patterns: scientific credibility must remain intact while commercial credibility is built in parallel. The marketing review handles both registers.
Yes. Berkeley signals research-grade operating altitude. Enterprise pharma and enterprise buyers interpret it as production-grade scientific credibility. The Bay Area signal has to support real proof.
Scientific PR amplifies the science. The marketing review builds the commercial frame around it. Different jobs, different formats, often used together. The marketing review produces the brief PR works against.
Marketing Strategy Review $5,000. Positioning Sprint $7,500. Paid Media Audit $2,500. Conversion Review $3,500. Marketing Partnership $4,500/month. AI Visibility Audit $2,500.
Most Berkeley agencies sell either scientific PR or generic SaaS marketing. The marketing review produces the commercial-strategy document research-led teams need but rarely have in writing.
Yes. Pre-launch positioning is one of the highest-advantage moments. NDA signed before any work begins. Confidentiality is a default for research-led operators.
The buying committee is the same shape, but the credibility stack is different. McKinsey 2024 puts the average B2B committee at 10 people across 10-plus interactions. At a Berkeley deep-tech vendor, that committee includes a scientific reviewer in addition to procurement and the economic buyer. Gartner 2024 still applies: about 70 percent of the journey completes pre-contact. The strategy document has to work accurately to the scientific reviewer and the commercial buyer in the same pages.
Berkeley spin-outs commercializing university IP usually start with positioning, not channels. ICONIQ Growth 2023 puts the median B2B SaaS CAC payback at about 15 months, and a deep-tech spin-out should expect a longer enterprise sales cycle on top of that. ICONIQ Capital 2024 publishes Series B sales-efficiency benchmarks the board references at the next raise. Pavilion 2024 has fractional CMO retainers from $12K to $25K depending on ARR band. The Marketing Strategy Review at $5,000 is the most common entry.
of the B2B buying journey is complete before vendor contact. For research-led teams, the page must qualify the scientific reviewer before the call.
Gartner · Future of B2B Sales · 2024
people on the average B2B buying committee, across 10-plus interactions. In Berkeley deep-tech, one of them reads the science.
McKinsey · B2B Pulse · 2024
match rate between vendor self-description and buyer experience. The gap is widest when the science is strong and the commercial frame is missing.
TrustRadius · B2B Buying Disconnect · 2023
No invented benchmarks. Every number above traces to a publisher, a year, and a public URL in the citations section at the bottom of this page.
No invented East Bay benchmark. Every row below has a publisher, a year, and a public URL in the citations section.
| Source | Year | Finding relevant to Berkeley operators |
|---|---|---|
| McKinsey · B2B Pulse Survey | 2024 | Committees average 10 people, 10-plus interactions. Berkeley deep-tech committees include a scientific reviewer alongside procurement. |
| ICONIQ Growth · SaaS Benchmarks | 2023 | Median B2B SaaS CAC payback is about 15 months. Spin-outs with enterprise cycles should plan for a longer curve on top. |
| ICONIQ · State of the Cloud | 2024 | Series B sales-efficiency benchmarks the Berkeley board will reference at the next raise. |
Four-axis commercial strategy for research-led operators.
Open the offer →Category narrative bridging scientific and commercial credibility.
Open the offer →Answer-engine query coverage for research-led category claims.
Open the offer →The page should explain who the offer is for, which buyer problem it addresses, and why a local operator should trust the strategy before adding spend.
Client-specific numbers stay private unless approved. Public proof is shown through method, source trail, offer fit, and the marketing review questions a serious buyer can inspect.
The page points the buyer to a fixed-scope marketing review, not an open-ended sales call. The document is the first deliverable.
Berkeley companies often come from deep tech, biotech, climate, education, and research-led categories. Credibility has to be earned through proof, not polish alone.
The page keeps the work grounded in evidence: what the buyer has to believe, what can be verified, and what must change in the page or sales path.
Use this page when expert-led companies need a clearer commercial argument.
Scientific credibility is the foundation. Commercial narrative is the advantage.
Start with the Marketing Strategy Review · $5,000 →Use this page when you are comparing San Francisco Bay Area marketing help for a Berkeley company with real pipeline pressure.
Decide whether the problem is local positioning, buyer proof, channel economics, website conversion, or the lack of a written 90-day plan.
Use the review when leadership needs a written priority map and 90-day path before more spend.
Marketing Strategy Review →